INTRODUCTION: Chemotherapy during pregnancy can increase the risk of fetal anemia. Severe fetal anemia can lead to the development of hydrops fetalis and potentially fetal demise. Hence, it is imperative to implement consistent monitoring methods in the context of chemotherapy treatment. This study aimed to diagnose and monitor fetal anemia using middle cerebral artery peak systolic velocity (MCA-PSV) as a diagnostic tool during chemotherapy in pregnant women. MATERIAL AND METHODS: The study employed a prospective analysis involving a case series of 15 patients diagnosed with cancer during pregnancy and subsequently underwent chemotherapy. MCA-PSV was used to identify fetal anemia. The patients were scheduled for ultrasound examinations of the MCA-PSV. The first examination was performed on the same day as the administration of chemotherapy, while the second occurred on the 10th day after chemotherapy. The measurement technique used in the study was based on the methodology proposed by Mari and Barr. The multiples of the median were calculated using the calculators provided by Medicina Fetal Barcelona. Based on these values anemia severity was determined. When moderate or severe anemia was identified, chemotherapy was individually modified. Additionally, a blood count analysis was conducted immediately after the delivery of the newborn. RESULTS: Five patients were diagnosed with fetal or newborn anemia. With MCA-PSV, we identified moderate fetal anemia in two patients and severe fetal anemia in one. The complete blood count testing of newborns revealed mild anemia in three patients. One case was unrelated to chemotherapy-induced anemia. During treatment, fetal anemia did not corelate with maternal anemia. CONCLUSIONS: In four cases of anemia the combination of cisplatin and iphosphamide was used as a chemotherapy agent. No anemia was observed in other drug combinations. Our findings suggest that MCA-PSV is a reliable method for identifying anemia and should be included in the treatment protocol for chemotherapy-induced fetal anemia.

Department of Obstetrics and Gynecology University Hospital Kralovske Vinohrady 3rd Medical Faculty Charles University Prague Prague Czech Republic

Department of Oncology University Hospital Kralovske Vinohrady 3rd Medical Faculty Charles University Prague Prague Czech Republic

Zobrazit více v PubMed

Maggen C, Wolters V, Cardonick E, et al. Pregnancy and cancer: the INCIP project. Curr Oncol Rep. 2020;22(2):17. PubMed PMC

Amant F, Berveiller P, Boere IA, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019;30(10):1601‐1612. PubMed

de Haan J, Verheecke M, Van Calsteren K, et al. Oncological management and obstetric and neonatal outcomes for women diagnosed with cancer during pregnancy: a 20‐year international cohort study of 1170 patients. Lancet Oncol. 2018;19(3):337‐346. PubMed

Eibye S, Kjær SK, Mellemkjær L. Incidence of pregnancy‐associated cancer in Denmark, 1977‐2006. Obstet Gynecol. 2013;122(3):608‐617. PubMed

Marnitz S, Köhler C, Oppelt P, et al. Cisplatin application in pregnancy: first in vivo analysis of 7 patients. Oncology. 2010;79(1–2):72‐77. PubMed

Van Calsteren K, Verbesselt R, Ottevanger N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand. 2010;89(10):1338‐1345. PubMed

Esposito S, Tenconi R, Preti V, Groppali E, Principi N. Chemotherapy against cancer during pregnancy: a systematic review on neonatal outcomes. Medicine (Baltimore). 2016;95(38):e4899. PubMed PMC

Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5(5):283‐291. PubMed

Barr JJ, Mari G. Cerebral blood flow velocity waveforms and fetal anemia. In: Maulik D, Lees CC, eds. Doppler Ultrasound in Obstetrics and Gynecology. Springer International Publishing; 2023:297‐311.

Moise KJ. The usefulness of middle cerebral artery Doppler assessment in the treatment of the fetus at risk for anemia. Am J Obstet Gynecol. 2008;198(2):161.e1‐161.e4. PubMed

Imbar T, Lev‐Sagie A, Cohen S, Yanai N, Yagel S. Diagnosis, surveillance, and treatment of the anemic fetus using middle cerebral artery peak systolic velocity measurement. Prenat Diagn. 2006;26(1):45‐51. PubMed

Mari G, Deter RL, Carpenter RL, et al. Non‐invasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red‐cell alloimmunization. Collaborative Group for Doppler Assessment of the blood velocity in anemic fetuses. N Engl J Med. 2000;342(1):9‐14. PubMed

Society for Maternal‐Fetal Medicine (SMFM) . Electronic address: pubs@smfm.org, Mari G, Norton ME, et alSociety for Maternal‐Fetal Medicine (SMFM) clinical guideline #8: the fetus at risk for anemia—diagnosis and management. Am J Obstet Gynecol. 2015;212(6):697‐710. PubMed

Amant F, Halaska MJ, Fumagalli M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer. 2014;24(3):394‐403. PubMed

Mari G, Abuhamad AZ, Cosmi E, Segata M, Altaye M, Akiyama M. Middle cerebral artery peak systolic velocity: technique and variability. J Ultrasound Med. 2005;24(4):425‐430. PubMed

Halaska MJ, Komar M, Vlk R, et al. A pilot study on peak systolic velocity monitoring of fetal anemia after administration of chemotherapy during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2014;174:76‐79. PubMed

Ramirez MM, Litton J, Theriault RL, Mastrobattista JM. P32.08: fetal anemia screening using MCA velocities in women receiving chemotherapy during pregnancy. Ultrasound Obstet Gynecol. 2008;32(3):422.

Fruscio R, Villa A, Chiari S, et al. Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: a series of nine cases and literature review. Gynecol Oncol. 2012;126(2):192‐197. PubMed

Hanna TP, King WD, Thibodeau S, et al. Mortality due to cancer treatment delay: systematic review and meta‐analysis. BMJ. 2020;371:m4087. PubMed PMC

Bernardini F, Ferrandina G, Ricci C, et al. Neoadjuvant chemotherapy in pregnant patients with cervical cancer: a monocentric retrospective study. Curr Oncol. 2022;29(8):5702‐5714. PubMed PMC

Huang H, Quan Y, Qi X, Liu P. Neoadjuvant chemotherapy with paclitaxel plus cisplatin before radical surgery for locally advanced cervical cancer during pregnancy. Medicine (Baltimore). 2021;100(32):e26845. PubMed PMC

Köhler C, Oppelt P, Favero G, et al. How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy. Am J Obstet Gynecol. 2015;213(2):206.e1‐206.e5. PubMed

Prefumo F, Fichera A, Fratelli N, Sartori E. Fetal anemia: Diagnosis and management. Best Pract Res Clin Obstet Gynaecol. 2019;58:2‐14. PubMed

Oepkes D, Adama van Scheltema P. Intrauterine fetal transfusions in the management of fetal anemia and fetal thrombocytopenia. Semin Fetal Neonatal Med. 2007;12(6):432‐438. PubMed

World Health Organization . Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. World Health Organization; 2011. Accessed August 22, 2023. https://apps.who.int/iris/handle/10665/85839

Tailoring neoadjuvant chemotherapy for a pregnant patient diagnosed with IB2 squamous cervical carcinoma